This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Treatment-resistant depression is a condition that affects individuals diagnosed with Major Depressive Disorder (MDD) who have tried at least two antidepressant medications, but the treatment proved ineffective in reducing or relieving the symptoms. Common antidepressants like Prozac or Zoloft are often prescribed to people with depression. Although these medications provide positive results for some people, over 40% of those with MDD are unresponsive to antidepressants and are considered to have treatment-resistant depression. Some people who have treatment-resistant depression may feel relief for brief periods of time while taking antidepressants, only to have the symptoms return again. The intolerable side effects often associated with medication, such as insomnia, headaches, and diarrhea are just more reasons for people to cease taking the medications and be left with no better solution.
Many people who suffer from treatment-resistant depression feel helpless in their constant search for relief from the symptoms. There are very limited treatment options that are safe, easily administered, and free of side effects. Thankfully BrainsWay can provide individuals who have treatment-resistant depression with hope. BrainsWay’s FDA cleared and patented treatment known as Deep TMS or Transcranial Magnetic Stimulation is a treatment for people with depression or OCD. Deep TMS is a noninvasive, outpatient procedure with no systemic side effects and fits into peoples’ daily routines.
BrainsWay’s Deep TMS is even more advanced than standard TMS systems because it is able to penetrate deeper into the brain, covering a wider region and therefore increasing the accuracy and effectiveness of the treatment. For those with treatment-resistant Depression, BrainsWay’s Deep TMS offers an intriguing alternative that has been shown to be well-tolerated and clinically proven to show results in treating people suffering from MDD. BrainsWay is also the only TMS system to receive FDA clearance for its treatment of OCD. With a success rate of over 50% for the MDD treatment, the Brainsway system is highly recommended among psychiatric medical professionals for those who are shown to be resistant to other treatments.
BrainsWay uses an innovative and state-of-the-art helmet design to carry out Deep TMS treatment. The helmet is designed for comfort and ease of use. You will be seated in a comfortable chair and fitted with the helmet-like device. During each 20-minute session, you are free to read a magazine or use your phone and can safely drive yourself to and from sessions. Treatment frequency is five times per week for four-six weeks and additional biweekly sessions as needed for maintenance. The BrainsWay Deep TMS system is an advanced technology that provides individuals with treatment-resistant depression another chance at remission.